|
US5773252A
(en)
|
1995-06-05 |
1998-06-30 |
Human Genome Sciences, Inc. |
Fibroblast growth factor 15
|
|
EP1005544A4
(en)
|
1997-08-19 |
2004-07-14 |
Human Genome Sciences Inc |
70 HUMAN, SECRETED PROTEINS
|
|
US20030130182A1
(en)
*
|
1997-11-05 |
2003-07-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU764441B2
(en)
|
1998-02-09 |
2003-08-21 |
Genset S.A. |
cDNAs encoding secreted proteins
|
|
US7160679B1
(en)
|
1998-05-21 |
2007-01-09 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging lung cancer
|
|
US7291712B2
(en)
|
1998-06-25 |
2007-11-06 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
US20020172678A1
(en)
*
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
|
US7264801B2
(en)
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
|
US20030003507A1
(en)
|
1999-06-02 |
2003-01-02 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
ATE413466T1
(de)
|
1998-09-02 |
2008-11-15 |
Diadexus Inc |
Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen
|
|
CA2341326A1
(en)
*
|
1998-09-03 |
2000-03-16 |
Takeda Chemical Industries, Ltd. |
Novel protein and process for producing the same
|
|
US7014996B1
(en)
|
1998-10-02 |
2006-03-21 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
|
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
|
AU2007216683B2
(en)
*
|
1998-12-17 |
2011-07-14 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US6468546B1
(en)
|
1998-12-17 |
2002-10-22 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US6962980B2
(en)
|
1999-09-24 |
2005-11-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US7888477B2
(en)
|
1998-12-17 |
2011-02-15 |
Corixa Corporation |
Ovarian cancer-associated antibodies and kits
|
|
CA2356987A1
(en)
*
|
1998-12-23 |
2000-06-29 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US7083791B2
(en)
|
1999-03-25 |
2006-08-01 |
Genesis Research & Development Corporation Limited |
Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
|
|
US6242419B1
(en)
*
|
1999-03-25 |
2001-06-05 |
Genesis Research & Development Corporation Ltd. |
Compositions isolated from stromal cells and methods for their use
|
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
AU7573000A
(en)
*
|
1999-09-01 |
2001-03-26 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1623991A3
(en)
*
|
1999-09-01 |
2006-06-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1220919A2
(en)
*
|
1999-09-29 |
2002-07-10 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Metastasis-associated antigen c4.4a
|
|
JP4741139B2
(ja)
*
|
1999-12-23 |
2011-08-03 |
ザイモジェネティクス， インコーポレイテッド |
可溶性インターロイキン−２０レセプター
|
|
US6610286B2
(en)
|
1999-12-23 |
2003-08-26 |
Zymogenetics, Inc. |
Method for treating inflammation using soluble receptors to interleukin-20
|
|
US7122632B2
(en)
|
1999-12-23 |
2006-10-17 |
Zymogenetics, Inc. |
Soluble Interleukin-20 receptor
|
|
CA2390685C
(en)
*
|
2000-01-06 |
2008-04-22 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
EP1947182A1
(en)
*
|
2000-02-15 |
2008-07-23 |
Amgen Inc. |
Fibroblast growth factor-23 molecules and uses thereof
|
|
CA2398603A1
(en)
*
|
2000-02-15 |
2001-08-23 |
Amgen, Inc. |
Fibroblast growth factor-23 molecules and uses thereof
|
|
US7135303B2
(en)
|
2000-02-28 |
2006-11-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
|
|
AU6802801A
(en)
*
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030105302A1
(en)
*
|
2000-03-08 |
2003-06-05 |
Nobuyuki Itoh |
Human FGF-23 gene and gene expression products
|
|
AU2001249125A1
(en)
*
|
2000-03-08 |
2001-09-17 |
Chiron Corporation |
Human fgf-23 gene and gene expression products
|
|
US20030158382A1
(en)
|
2000-04-21 |
2003-08-21 |
Nobutaka Wakamiya |
Novel collectins
|
|
CA2407746A1
(en)
*
|
2000-05-04 |
2001-11-08 |
Incyte Genomics, Inc. |
Proteases
|
|
US6897286B2
(en)
|
2000-05-11 |
2005-05-24 |
Zymogenetics, Inc. |
Zsig33-like peptides
|
|
ATE473280T1
(de)
*
|
2000-05-11 |
2010-07-15 |
Zymogenetics Inc |
Zsig33-ähnliche peptide
|
|
EP1176200A3
(de)
|
2000-06-20 |
2005-01-12 |
Switch Biotech Aktiengesellschaft |
Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
|
|
AU2001273194A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Amgen Inc. |
B7-Like Molecules and Uses Thereof
|
|
ATE364698T1
(de)
|
2000-07-18 |
2007-07-15 |
Takeda Pharmaceutical |
Neues, physiologisch aktives peptid und dessen verwendung
|
|
ES2340662T3
(es)
|
2000-07-19 |
2010-06-08 |
Advanced Research And Technology Institute |
Factor de crecimiento de fibroblastos (fgf23) nuevo procedimiento para el uso.
|
|
KR100886276B1
(ko)
|
2000-08-11 |
2009-03-04 |
기린 파마 가부시끼가이샤 |
인산 대사, 칼슘 대사, 석회화 및 비타민 ｄ 대사를조절하는 폴리펩티드 및 그것을 코딩하는 ｄｎａ
|
|
CA2632702A1
(en)
*
|
2000-09-01 |
2002-03-28 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2002036625A2
(en)
|
2000-11-03 |
2002-05-10 |
The Regents Of The University Of California |
Prokineticin polypeptides, related compositions and methods
|
|
JPWO2002052009A1
(ja)
*
|
2000-12-26 |
2004-04-30 |
中外製薬株式会社 |
血中リン濃度を低下させるヒトｆｇｆ２３タンパク質変異体
|
|
EP1873245A1
(en)
*
|
2001-02-28 |
2008-01-02 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
EP1881007A1
(en)
*
|
2001-03-27 |
2008-01-23 |
Novartis AG |
LLR-J24 related proteins
|
|
US6734289B2
(en)
*
|
2001-03-29 |
2004-05-11 |
The University Of Chicago |
Gastrokines and derived peptides including inhibitors
|
|
US7033790B2
(en)
|
2001-04-03 |
2006-04-25 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
US7736654B2
(en)
|
2001-04-10 |
2010-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
WO2003002737A1
(fr)
*
|
2001-06-27 |
2003-01-09 |
Riken |
Nouvelle proteine inhibitrice de la topoisomerase humaine 2$g(a) et utilisation associee
|
|
IL159872A0
(en)
*
|
2001-07-26 |
2004-06-20 |
Genset Sa |
Gmg-2 polypeptides and their use
|
|
DE60329070D1
(de)
|
2001-12-28 |
2009-10-15 |
Kyowa Hakko Kirin Co Ltd |
Antikörper gegen den fibroblastenwachstumsfaktor 23
|
|
US20060263770A1
(en)
*
|
2002-03-22 |
2006-11-23 |
Marco Colonna |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
|
AU2002303430A1
(en)
*
|
2002-04-23 |
2003-11-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
JP4333880B2
(ja)
*
|
2002-05-31 |
2009-09-16 |
生化学工業株式会社 |
コンドロイチン合成酵素および該酵素をコードするｄｎａ
|
|
AU2003261911A1
(en)
*
|
2002-09-04 |
2004-03-29 |
Takeda Pharmaceutical Company Limited |
Use of disease-associated gene
|
|
WO2004042055A1
(ja)
*
|
2002-11-07 |
2004-05-21 |
National Institute Of Advanced Industrial Science And Technology |
骨パジェット病の検出方法
|
|
US7411048B2
(en)
|
2002-11-19 |
2008-08-12 |
Drg International, Inc. |
Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids
|
|
US8017737B2
(en)
|
2002-11-19 |
2011-09-13 |
Hasan Kulaksiz |
Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor
|
|
CA2506668C
(en)
|
2002-11-19 |
2014-08-19 |
Drg International, Inc. |
Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
|
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
US7312197B2
(en)
|
2003-02-24 |
2007-12-25 |
University Of Maryland, Baltimore |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
|
|
JP4912144B2
(ja)
|
2003-03-12 |
2012-04-11 |
ジェネンテック， インコーポレイテッド |
造血促進のためのｂｖ８及び／又はｅｇ−ｖｅｇｆの使用
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
EP1633882B1
(en)
*
|
2003-05-28 |
2008-05-14 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with puromycin-insensitive leucyl-specific aminopeptidase (pils)
|
|
SI2295073T1
(sl)
*
|
2003-11-17 |
2014-07-31 |
Genentech, Inc. |
Protitelo proti CD22 za zdravljenje tumorja hematopoetskega izvora
|
|
EP1696963A2
(en)
*
|
2003-12-24 |
2006-09-06 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
WO2005068497A1
(en)
*
|
2004-01-06 |
2005-07-28 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Iis: a novel ifn-gamma-inducible protein, member of the secretoglobin family, that modulates cellular invasion and migration
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
JP2006034189A
(ja)
*
|
2004-07-28 |
2006-02-09 |
National Institute Of Advanced Industrial & Technology |
組織の癌化の検出方法
|
|
US7544659B2
(en)
|
2004-08-13 |
2009-06-09 |
Genentech, Inc. |
Promotion of axonal regeneration
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
AU2006321553B2
(en)
|
2005-12-08 |
2012-03-08 |
E. R. Squibb & Sons, L.L.C. |
Human monoclonal antibodies to O8E
|
|
CN100460013C
(zh)
*
|
2006-09-05 |
2009-02-11 |
重庆康卫生物科技有限公司 |
口服重组幽门螺杆菌疫苗及其制备方法
|
|
US8058014B2
(en)
|
2006-09-29 |
2011-11-15 |
University Of Maryland, Baltimore |
Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2
|
|
US7883705B2
(en)
|
2007-02-14 |
2011-02-08 |
Kyowa Hakko Kirin Co., Ltd. |
Anti FGF23 antibody and a pharmaceutical composition comprising the same
|
|
PE20091261A1
(es)
|
2007-11-02 |
2009-08-17 |
Lilly Co Eli |
Anticuerpos anti-hepcidina
|
|
EA201170312A1
(ru)
|
2008-08-06 |
2012-03-30 |
Эли Лилли Энд Компани |
Селективные антитела к гепцидину-25 и их применение
|
|
BR112012021576A2
(pt)
|
2010-02-26 |
2016-10-25 |
Novo Nordisk As |
composições estáveis contendo anticorpo.
|
|
RU2012153786A
(ru)
|
2010-05-28 |
2014-07-10 |
Ново Нордиск А/С |
Стабильные многодозовые композиции, содержащие антитело и консервант
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
EP3385277A1
(en)
|
2013-03-15 |
2018-10-10 |
F. Hoffmann-La Roche AG |
Il-22 polypeptides and il-22 fc fusion proteins and methods of use
|